Most People Initiating Opioid Rx Have Very Low Use Trajectory
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, Aug. 14, 2023 -- Most adults initiating treatment with prescription opioids have relatively low and time-limited exposure to opioids during a five-year period, according to a study published online Aug. 10 in JAMA Network Open.
Natasa Gisev, Ph.D., from the National Drug and Alcohol Research Centre in Sydney, and colleagues examined five-year trajectories of prescription opioid use. The analysis included national pharmaceutical claims data linked to 10 national and state datasets for 3.47 million adults initiating an opioid prescription.
The researchers found that the five trajectories included: very low use (75.4 percent), low use (16.6 percent), moderate decreasing to low use (2.6 percent), low increasing to moderate use (2.6 percent), and sustained use (2.8 percent). Individuals in the sustained use trajectory group were older than those in the very low use trajectory group (age 65 years and older: 58.4 versus 22.0 percent); had more comorbidities, including cancer (22.2 versus 4.1 percent); had increased health services contact, including hospital admissions (51.6 versus 36.9 percent); had higher use of psychotropic (42.4 versus 16.4 percent) and other analgesic drugs (47.3 versus 22.9 percent) prior to opioid initiation; and were initiated on stronger opioids (50.2 versus 20.0 percent).
"Information on the individual characteristics of people with different trajectories of opioid use may be used to prevent future harms from long-term opioid use through targeted monitoring and interventions," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Nudging Both Clinicians, Patients May Increase Serious Illness Conversations
TUESDAY, July 2, 2024 -- Combining clinician- and patient-directed nudges may help to promote serious illness conversations (SICs) in cancer care, according to a study published...
Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer
TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...
Racial Differences Seen in Financial Hardship Among Older Cancer Survivors
MONDAY, July 1, 2024 -- Income and area-level disadvantage are the largest contributors to racial differences in financial hardship among older U.S. adults with cancer, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.